Show simple item record

dc.contributor.authorLamarca, Angela
dc.contributor.authorSantos-Laso, A.
dc.contributor.authorUtpatel, K.
dc.contributor.authorLa Casta, A.
dc.contributor.authorStock, S.
dc.contributor.authorForner, A.
dc.contributor.authorAdeva, J.
dc.contributor.authorFolseraas, T.
dc.contributor.authorFabris, L.
dc.contributor.authorMacias, R. I. R.
dc.contributor.authorKrawczyk, M.
dc.contributor.authorKrawczyk, M.
dc.contributor.authorCardinale, V.
dc.contributor.authorBraconi, C.
dc.contributor.authorAlvaro, D.
dc.contributor.authorEvert, M.
dc.contributor.authorBanales, J. M.
dc.contributor.authorValle, Juan W
dc.date.accessioned2021-09-30T11:56:09Z
dc.date.available2021-09-30T11:56:09Z
dc.date.issued2021en
dc.identifier.citationLamarca A, Santos‐Laso A, Utpatel K, La Casta A, Stock S, Forner A, et al. REPLY: Hepatology. 2021 Aug;74(2):1129–31.en
dc.identifier.pmid33550618en
dc.identifier.doi10.1002/hep.31740en
dc.identifier.urihttp://hdl.handle.net/10541/624628
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1002/hep.31740en
dc.titleLetter to the editor: does multiple intrahepatic cholangiocarcinoma worsen prognosis as 'M1' stage? Replyen
dc.typeOtheren
dc.contributor.departmentMedical Oncology/Institute of Cancer Sciences, The Christie NHS Foundation Trust/University of Manchester, Manchesteren
dc.identifier.journalHepatologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record